Publications by authors named "Richard Wadas"

Claim this Profile
D
Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH).
Kristin Mayes, Victor B Talisa, Adelina Malito, Florian B Mayr, Kelly Williams, Richard Wadas

Contemp Clin Trials Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH)" [Contemp. Clinic. Trials Commun. 46 (2025) 101504].
Kristin Mayes, Victor B Talisa, Adelina Malito, Florian B Mayr, Kelly Williams, Richard Wadas

Contemp Clin Trials Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
Kevin E Kip, Erin K McCreary, Kevin Collins, Tami E Minnier, Graham M Snyder, Richard J Wadas

Ann Intern Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
Erin K McCreary, Kevin E Kip, Kevin Collins, Tami E Minnier, Graham M Snyder, Richard J Wadas

Open Forum Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Erin K McCreary, J Ryan Bariola, Tami E Minnier, Richard J Wadas, Judith A Shovel

Contemp Clin Trials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
David T Huang, Erin K McCreary, J Ryan Bariola, Tami E Minnier, Richard J Wadas

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
Erin K McCreary, J Ryan Bariola, Richard J Wadas, Judith A Shovel, Mary Kay Wisniewski

JAMA Netw Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Erin K McCreary, J Ryan Bariola, Tami Minnier, Richard J Wadas, Judith A Shovel

Contemp Clin Trials· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
Thomas J Woltemate, Richard J Wadas, Erin K McCreary, Ryan Bariola, Tami Minnier

J Am Coll Emerg Physicians Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Ryan Bariola, Erin K McCreary, Richard J Wadas, Kevin E Kip, Oscar C Marroquin

Open Forum Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic.
J Ryan Bariola, Erin K McCreary, Tina Khadem, Graham M Snyder, Richard J Wadas

Open Forum Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
David T Huang, Erin K McCreary, J Ryan Bariola, Richard J Wadas, Kevin E Kip

Trials· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative assessment of adverse event classification in the out-of-hospital setting.
P Daniel Patterson, Judith R Lave, Matthew D Weaver, Francis X Guyette, Robert M Arnold, Richard J Wadas

Prehosp Emerg Care· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring adverse events in helicopter emergency medical services: establishing content validity.
P Daniel Patterson, Judith R Lave, Christian Martin-Gill, Matthew D Weaver, Richard J Wadas

Prehosp Emerg Care· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel method for continuous environmental surveillance for carbon monoxide exposure to protect emergency medical service providers and patients.
Brian L Risavi, Richard J Wadas, Cecil Thomas, Douglas F Kupas

J Emerg Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMS and emergency department physician triage: injury severity in trauma patients transported by helicopter.
Jeffrey S Lubin, Theodore R Delbridge, John S Cole, Dederia H Nicholas, Christopher A Fore, Richard J Wadas

Prehosp Emerg Care· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis